NWF Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
NWF Advisory Services's BMY Position: Q2 2026 in Review
NWF Advisory Services reduced its Bristol-Myers Squibb (BMY) stake by 4.7% in Q2 2026, selling an estimated $17.8K and leaving 6,255 shares worth $360K. The position accounts for 0.03% of the portfolio, ranked #275.
NWF Advisory Services first reported a position in BMY in Q1 2023 and has held it in 13 quarters since. The position peaked at $399K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- NWF Advisory Services held 6,255 shares of Bristol-Myers Squibb worth $360K as of Q2 2026.
- NWF Advisory Services sold 310 Bristol-Myers Squibb shares in Q2 2026, an estimated $17.8K.
- Bristol-Myers Squibb made up 0.03% of NWF Advisory Services's portfolio in Q2 2026, its #275 holding.
- NWF Advisory Services first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 13 quarters since.
- NWF Advisory Services's Bristol-Myers Squibb position peaked at $399K in Q1 2025.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on NWF Advisory Services's 13F filing for Q2 2026, filed 29 Jul 2026.